Welcome!

.NET Authors: Elizabeth White, Kevin Benedict, Tim Hinds, Jayaram Krishnaswamy, Pat Romanski

News Feed Item

Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017

NEW YORK, Dec. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017

http://www.reportlinker.com/p01054644/Hospital-based-Point-of-Care-Diagnostics-Products-Players-and-Outlook-to-2017 .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Clinical and patient benefits are driving the Hospital-based Point-of-Care product sector, which achieved growth of 7.5% in 2011

US$2.9 billion

The benefits are clear. Hospital-based POC diagnostics offer healthcare providers an opportunity to improve the quality of patient care while saving time and reducing costs. A faster diagnosis can mean a faster medical intervention, potentially avoiding the need to admit a patient into hospital and the costs incurred as a result, while also freeing up that hospital bed.

The integration of IT connectivity and data management features enables POC analysers to communicate with hospital IT systems and electronic patient records in order to increase efficiency, facilitate quality control and reduce the chance of user error.

The development of new technologies that enable DNA analysis and the identification of hospital-acquired infections such as MRSA at the point of care.

The patient experience is improved with shorter waiting times and hospital stays, and lower rates of hospital-acquired infections.

Automated calibration, processing and operation features eliminate the need for medical staff to add reagents or undertake manual handling steps as errors in these areas can impact patient safety and the accuracy of POC test results.

Challenges remain...

This new November 2012 report delivers a complete analysis

This new 182-page highly-detailed report Hospital-based Point-of-Care Diagnostics: Products, Players and Outlook to 2017 provides executives with a complete understanding of the issues which are shaping the market and how that will affect its commercial development. This is Volume 2 of a 4-Volume study of the whole POC IVD sector to be published late 2012/early 2013. See overleaf for more details and discounts.

Focus on...

The Competitive Environment

There are around 80 companies active in the hospital POC diagnostics market, although many are development-stage or have limited product portfolios. The market is currently dominated by Alere (previously Inverness Medical Innovations), Abbott, Radiometer, Roche and Siemens. Currently, Abbott, Radiometer, Roche and Siemens have strong positions in the markets for clinical chemistry and blood gas analysis; Abbott, Alere and Roche are leaders for POC cardiac marker testing; and Beckman Coulter, Quest Diagnostics, Horiba and Sysmex are key companies in POC haematology diagnostics.

Contents

EXECUTIVE SUMMARY...1

INTRODUCTION2

POC Testing in a Hospital Setting...2

CURRENT MARKET DYNAMICS ..4

Fig.1: POC Diagnostics in Relation to the IVD Market, 2011.4

Fig.2: Percentage of POC Diagnostics Market by Product, 2011..5

Regional Perspective ..5

Fig.3: Professional POC Diagnostics Market by Region, 2011..6

Regulatory and Reimbursement Environment6

CLIA Waiver.6

Hospital POC Testing Market..7

Hospital POC Testing Market by Product Type, 2007-2011 (US$ million)8

Fig.4: Hospital POC Testing Market by Product Type, 2011..8

COMPETITIVE LANDSCAPE.9

Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million)...9

Market Leaders by Hospital POC Testing Product Type...9

Merger and Acquisition Activity ..10

Key Hospital POC Diagnostics Mergers and Acquisitions, 2008-2012...10

GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES..12

Clinical Utility and Accuracy.12

Connectivity...12

POC Diagnostics as a Disruptive Technology..13

POC Diagnostics and the Economy..14

Future Technology: Next-Generation POC Diagnostic Products..14

Lab-on-a-Chip Devices and Microfluidics...14

Detecting Hospital-Acquired Infections.15

Summary: Market Drivers, Restraints and Opportunities16

FUTURE MARKET PROSPECTS..17

Hospital POC Testing Market by Product Type, 2011-2017E (US$ million).17

Hospital POC Testing Market by Product Growth, 2008-2017E (%)..18

Fig.5: Predicted Hospital POC Testing Market by Product, 201718

HOSPITAL POC TESTING PRODUCTS AND TECHNOLOGIES.19

MULTI-FUNCTIONAL CLINICAL CHEMISTRY ANALYSERS 19

Abaxis' Piccolo xpress ...19

Abbott's i-STAT System .20

Alfa Wassermann's ACE Clinical Chemistry Systems ..21

Arkray's SpotChem Systems 22

SpotChem Test Strips..22

Audit Diagnostics' Liqui-Stat and DryLab Systems22

DiaSys Diagnostic Systems' InnovaStar ..23

Horiba's ABX Pentra Clinical Chemistry Analysers .23

Ortho-Clinical Diagnostics' VITROS DT60 II Chemistry System.23

Radiometer's AQT90 FLEX Immunoassay Analyser24

Randox Laboratories' Evidence Multistat...24

Samsung's LABGEO Clinical Chemistry Analysers..25

Tosoh Bioscience's AIA Immunoassay Analysers25

POC BLOOD GAS/ELECTROLYTE ANALYSERS27

Fig.6: POC Clinical Chemistry Market, 2007-2017E (US$ million)..27

Arkray's SpotChem EL Electrolyte Analyser28

Epocal's epoc Blood Analysis System ..28

Instrumentation Laboratory's GEM Premier Products .29

tBili Assay..29

November 2012 iii

Hospital Point-of-Care Diagnosticsiv

Table of Contents Hospital Point-of-Care Diagnostics

GEMweb Plus .. 29

ITC's IRMA TRUpoint Blood Analysis System...30

ITC's AVOXimeter Products...30

Nova Biomedical's Critical Care Analysers ..30

pHOx Ultra Blood Gas Analyser... 30

Stat Profile pHOx 31

Stat Profile Critical Care Xpress 31

Nova Electrolyte/Chemistry Analysers...31

Hand-Held Analysers..32

OPTI Medical Systems' Products..32

Radiometer's Blood Gas Analysers ..32

1st automatic32

ABL90 FLEX ..33

ABL800 FLEX.33

Avoid Errors App 34

Roche's cobas Blood Gas Analysers .34

Siemens' Blood Gas Analyser Range ...35

RAPIDPoint Analysers.35

RAPIDLab Analysers... 36

RAPIDChem 744/754 Electrolyte and Lithium Testing ... 36

RAPIDComm Data Management and Connectivity Solution 36

Via Medical's Products ..37

POC HAEMATOLOGY AND HAEMOSTASIS PRODUCTS... 38

Fig.7: Global POC Haematotolgy Market, 2007-2017E (US$ million)...38

Haematology Analysers39

Beckman Coulter's COULTER AC•T Series ...39

Horiba's Haematology Analysers.39

Samsung's LABGEO HC10 ..41

Sysmex' pocH-100i Haematology Analyser ...41

POC Haemoglobin Systems ..41

POC Analyser Accuracy...42

Available Products 43

Arkray's PocketChem BA Blood Ammonia Meters 48

Surgical Coagulation and Haemostasis Management.. 48

Akers Biosciences' PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays 49

Haemonetics' TEG Thrombelastograph Hemostasis Analyzer.. 49

Medtronic's HMS PLUS Haemostasis Management System.. 50

Pentapharm's ROTEM delta.. 50

Sienco's Sonoclot Coagulation & Platelet Function Analyzers.. 50

Platelet Function Assessment..51

Clinical Guidelines...51

Accumetrics' VerifyNow System...52

Helena Laboratories' Plateletworks System..53

POC CARDIAC MARKER TESTING54

PROTECT Study55

VISION Study... 56

POC Testing56

Gaining Clinical Evidence...57

Market Dynamics... 58

Fig.6: Global POC Cardiac Marker Testing Market, 2007-2017E (US$ million) .58

POC Testing Products.59

Currently-Available Cardiac Marker POC Tests.59

POC URINALYSIS 69

Fig.9: Global POC Urinalysis Market, 2007-2017E (US$ million)...69

Key Urine Analysis Test Strips...70November 2012 v

Hospital Point-of-Care Diagnostics Table of Contents

Product Highlights 70

77 Elektronika's DocUReader 2 and DocuReader 2 Pro...70

ACON Laboratories' Mission Products.70

Arkray's Products71

Roche's Products.71

Siemens' Products.. 72

OTHER POC PRODUCTS 74

Labour and Delivery Testing 74

Alere's Triage PLGF Assay...74

Amnisure International's AmniSure ROM Test...75

Medix Biochemica's Actim PROM and Actim Partus.75

Liver Function Testing...76

Exalenz Bioscience's BreathID System76

Infopia's Pioneer POCT Liver Test Sensor76

Alere's Triage NGAL Test ...77

bioMérieux' VIDAS B•R•A•H•M•S PCT. Test...77

Magellan Biosciences' LeadCare II System..78

Medix Biochemica's Actim Pancreatitis ..78

Products in Development.78

Akers Biosciences' BreathPulmo Health Check and Breath Asthma Check 78

EMERGING TECHNOLOGIES.80

Applied Nanodetectors' Sensor Array Platform.80

Atonomics' Atolyzer..80

Ativa Medical's POC System..81

Bio-AMD's MPR..81

Biosensia's RapiPlex .82

Fiomi Diagnostics (Trinity Biotech) Forecast Technology..82

MagnaBioSciences' MICT On-Site System...83

Micronics' ABORhCard and ABO-XM Card...83

Molecular Vision .. 84

MycroLab... 84

OPKO Health's OPKO Diagnostics Platform 85

pes diagnosesysteme' respons IQ86

Philips' Minicare 86

Radisens Diagnostics' POC Platform ...87

T2 Biosystems' T2Dx System88

T2Hemostasis Assay .. 89

Tyrian Diagnostics' DiagnostIQ ...89

Hospital-Acquired Infection Testing ...90

Cepheid's GeneXpert..91

Atlas Genetics' POC System...92

BioFire Diagnostics' FilmArray System92

Immunexpress' SeptiCyte Technology ...93

Rheonix' EncompassMDx Platform 94

HOSPITAL POC TESTING MANUFACTURERS 95

COMPANY DIRECTORY. 95

SELECTED COMPANY PROFILES100

Abaxis .. 100

Piccolo xpress 100

Financial Performance 101

Abaxis Operating Results, 2007-2012 (US$ million)...101

Abbott ..102

Recent Key Events...102

i-STAT Point of Care Products. 102vi

Table of Contents Hospital Point-of-Care Diagnostics

Alliance with Abaxis. 104

Financial Performance 104

Abbott Point of Care Sales, 2010-2011 (US$ million).104

Fig.10: Percentage of Abbott Point of Care Revenue by Region, 2011104

Accumetrics .105

Recent Key Events...105

Fig.11: Accumetrics Revenue, 2005-2011 (US$ thousand).105

VerifyNow System 106

Distribution Agreements 107

Akers Biosciences 108

Recent Key Events...108

Current Products.. 109

Research and Development... 109

Current Alliances and Distribution Agreements.110

Financial Performance .111

Akers Biosciences Operating Results, 2007-2011 (US$ thousands).111

Fig.12: Percentage of Akers' Revenue by Product Type, 2011..112

Alere..113

Recent Key Events113

POC Cardiology Diagnostic Products114

Women's Health 116

RALS-Plus POC IT Solution...116

POC Mergers & Acquisitions117

Current Alliances...119

Financial Performance 120

Alere - Operating Results, 2007-2011 (US$ million)...121

Fig.13: Percentage of Alere's Revenue by Segment, 2011...121

Fig.14: Percentage of Alere's Revenue by Region, 2011..121

Alere Professional Diagnostics Operating Results, 2007-2011 (US$ million).122

Professional Diagnostics Net Sales & Services Revenue, 2007-2011 (US$ million) 122

Fig.15: Alere Professional Diagnostics Net Sales & Services Revenue by Product, 2011.122

Alere Consumer Diagnostics Operating Results, 2007-2011 (US$ million).122

Arkray ...124

Recent Key Events...124

POC Testing Products ..124

Current Alliances.. 126

bioMérieux...127

bioNexia POC Tests...127

VIDAS Tests.127

Current Alliances.. 128

Financial Performance 129

bioMérieux - Operating Results, 2007-2011 (EUR million).129

Fig.16: Percentage of bioMérieux' Revenue by Product Type, 2011130

Fig.17: Percentage of bioMérieux's Revenue by Region, 2011130

Horiba Medical.131

Recent Key Events...132

Haematology Analysers...132

ABX Pentra 400 Clinical Chemistry Analyser... 134

Pentra C200 Clinical Chemistry Analyser. 134

Financial Performance 134

Fig.18: Percentage of Horiba's Revenue by Division, 2011..134

Horiba Medical - Operating Results, 2007-2011 (¥ million)...135

Fig.19: Percentage of Horiba Medical's Revenue by Region, 2011..135

Fig.20: Percentage of Horiba Medical's Revenue by Product Type, 2011...135November 2012

Hospital Point-of-Care Diagnostics Table of Contents

Instrumentation Laboratory..137

Recent Key Events...137

POC Critical Care Diagnostics..137

Purchasing Contracts... 138

International Technidyne Corporation .139

Products. 139

Current Alliances.. 140

Financial Performance 140

International Technidyne Operating Results, 2004-2009 (US$ million)141

Fig.21: International Technidyne Revenue, 2000-2010 (US$ million)141

Nova Biomedical..142

Critical Care Analysers. 142

Hand-Held Analysers... 143

Quest Diagnostics144

HemoCue Products.. 144

Litigation with EKF Diagnostics. 146

Financial Performance 146

Quest Diagnostics - Operating Results, 2007-2011 (US$ million)..147

Quest Diagnostics - Sales and Earnings by Category, 2007-2011 (US$ million)147

Fig.22: Quest Diagnostics - Revenue by Division, 2011..147

Radiometer (Danaher) 149

Recent Key Events...149

AQT90 FLEX Immunoassay Analyser 150

Blood Gas Analysers 150

AQURE POC Management System 152

RADIANCE IT system 152

Current Alliances.. 152

Financial Performance 153

Fig.23: Radiometer - Revenue by Region, 2010.153

Response Biomedical..154

Recent Key Events...154

RAMP System 155

Current Alliances.. 156

Financial Performance 157

Response Biomedical - Operating Results, 2007-2011 (C$ thousands)..157

Response Biomedical - Product Sales by Category, 2009-2011 (C$ thousands)158

Fig.24: Response Biomedical - Product Sales by Category, 2011158

Response Biomedical - Revenue by Region, 2009-2011 (C$ thousands)...158

Fig.25: Response Biomedical - Revenue by Region, 2011...159

Roche Diagnostics ...160

Recent Key Events...160

Cardiac Testing Products.161

cobas Blood Gas Analysers..161

Urinalysis 162

cobas POC IT Solution.. 162

Current Alliances and Contracts 163

Financial Performance 163

Roche Diagnostics Operating Results, 2010-2011 (SFr million)..164

Fig.26: Roche Diagnostics - Revenue by Product Line, 2011..164

Fig.27: Roche Professional Diagnostics - Revenue by Region, 2011...164

Siemens Healthcare Diagnostics ...166

Recent Key Events...166

Blood Gas Analyser Range.. 166

Urinalysis 168

Cardiology - Stratus CS Analyzer... 169Table of Contents

Hospital Point-of-Care Diagnostics

RAPIDComm Data Management and Connectivity Solution...170

Current Alliances and Supply Contracts170

Financial Performance .170

APPENDICES ...172

APPENDIX 1 - LIST OF ABBREVIATIONS... 172

APPENDIX 2 - REPORT METHODOLOGY.. 173

To order this report:

In_Vitro_Diagnostic Industry: Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017

CONTACT:
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.